IP 1000 mg Metformin Hydrochloride Sustained Release
Jun 22, 2023
Metformin Hydrochloride Sustained Release IP 1000 mg
SEIZMET SR 1000
Metformin hydrochloride is a medication commonly used to treat type 2 diabetes. It is available in various formulations, including immediate-release and sustained-release formulations. The term "IP" refers to Indian Pharmacopoeia, which is a set of standards and guidelines for pharmaceuticals in India.
Metformin hydrochloride sustained-release IP 1000 mg refers to a specific formulation of metformin hydrochloride in which each tablet contains 1000 mg of the active ingredient. Sustained-release formulations are designed to release the medication slowly over an extended period, providing a steady and prolonged effect.
STERIS PHARMA Generic medicines are typically much cheaper than brand-name drugs. Generic medicines have the same active ingredients, strength, dosage form, and route of administration as their brand-name counterparts.
For further information please contact:
contact@sterispharma.com
order now:
https://www.sterisonline.com/product/seizmet-sr-1000-134083
Recent Post
Lurasidone Hydrochloride Price: A Complete Medical Insight
Rizatriptan Benzoate Orally Disintegrating Tablet: A Fast-Acting Solution for Migraine Relief
Mirabegron and Solifenacin succinate tablets uses
Linagliptin 5 mg Tablet: What You Need to Know Before Starting Treatment
Memantine 5mg Tablet Price, Uses & Where to Buy Safely Online
Enzalutamide Tablets: Effectiveness and Patient Experiences
Mycophenolate Mofetil 250 mg: Essential Information for Kidney Transplant Patients
Gabapentin and Lidocaine Hydrochloride Gel: Advanced Relief for Neuropathic Pain
Dapagliflozin and Metformin Tablet: A Dual-Action Approach to Blood Sugar Control
Glipizide 5 mg Tablet : Blood Sugar Management with A Patient-Friendly Guide